Immunology of pre- and probiotic supplementation

British Journal of Nutrition

Volumn 101, Issue 1, 2009, Pages 2-4

  Peppelenbosch, Maikel P ^a   Ferreira, Carmen V ^b  

^a UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

^b UNIVERSITY OF CAMPINAS   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA DEFENSIN; CD16 ANTIGEN; CD209 ANTIGEN; INTERLEUKIN 10; PREBIOTIC AGENT; PROBIOTIC AGENT;

ACUTE PANCREATITIS; ADAPTIVE IMMUNITY; ANTIINFLAMMATORY ACTIVITY; BACTERIAL COLONIZATION; BACTERIAL IMMUNITY; CLINICAL TRIAL; CLONAL ANERGY; COLITIS; CROHN DISEASE; DENDRITIC CELL; DIET SUPPLEMENTATION; ENTERITIS; HUMAN; IMMUNOLOGICAL TOLERANCE; INFECTION PREVENTION; INTESTINE FLORA; INTESTINE ISCHEMIA; INTESTINE MUCOSA; LACTOBACILLUS FERMENTUM; LACTOBACILLUS RHAMNOSUS; LACTOCOCCUS LACTIS; MUCOSAL IMMUNITY; NONHUMAN; NOTE; PANETH CELL; PROTECTION; SEPTIC SHOCK; SKIN ALLERGY; T LYMPHOCYTE ACTIVATION;

ANIMALS; DIETARY SUPPLEMENTS; HUMANS; IMMUNITY, CELLULAR; IMMUNITY, MUCOSAL; INTESTINAL MUCOSA; PROBIOTICS; SHOCK, SEPTIC;

EID: 57349147038     PISSN: 00071145     EISSN: 14752662     Source Type: Journal    
DOI: 10.1017/S0007114508020746     Document Type: Note

References (31)

1. Besselink MG, van Santvoort HC, Buskens E, et al. (2008) Dutch Acute Pancreatitis Study Group. Probiotic prophylaxis in predicted severe acute pancreatitis: A randomised, double-blind, placebo-controlled trial. Lancet 371, 651-659.
2. Arribas B, Elena Rodríguez-Cabezas M, Comalada M, Bailón E, Camuesco D, Olivares M, Xaus J, Zarzuelo A & Gálvez J (2008) Evaluation of the preventative effects exerted by Lactobacillus fermentum in an experimental model of septic shock induced in mice. Br J Nutr 101, 51-58 (epublication ahead of print version 29 April 2008).
3. Braat H, Peppelenbosch MP & Hommes DW (2006) Immunology of Crohn's disease. Ann N Y Acad Sci 1072, 135-154.
4. Comalada M & Peppelenbosch MP (2006) Impaired innate immunity in Crohn's disease. Trends Mol Med 12, 397-399.
5. Peran L, Camuesco D, Comalada M, Bailon E, Henriksson A, Xaus J, Zarzuelo A & Galvez J (2007) A comparative study of the preventative effects exerted by three probiotics, Bifido-bacterium lactis, Lactobacillus casei and Lactobacillus acidophilus, in the TNBS model of rat colitis. J Appl Microbiol 103, 836-844.
6. Madsen KL, Doyle JS, Jewell LD, Tavernini MM & Fedorak RN (1999) Lactobacillus species prevents colitis in interleukin 10 gene-deficient mice. Gastroenterology 116, 1107-1114.
7. Schultz M, Veltkamp C, Dieleman LA, Grenther WB, Wyrick PB, Tonkonogy SL & Sartor RB (2002) Lactobacillus plantarum 299V in the treatment and prevention of spontaneous colitis in interleukin-10-deficient mice. Inflamm Bowel Dis 8, 71-80.
8. Gionchetti P, Rizzello F, Venturi A, Brigidi P, Matteuzzi D, Bazzocchi G, Poggioli G, Miglioli M & Campieri M (2000) Oral bacteriotherapy as maintenance treatment in patients with chronic pouchitis: A double-blind, placebo-controlled trial. Gastroenterology 119 305-309.
9. Kalliomaki M, Salminen S, Poussa T, Arvilommi H & Isolauri E (2003) Probiotics and prevention of atopic disease: 4-year follow-up of a randomised placebo-controlled trial. Lancet 361, 1869-1871.
10. Kalliomaki M, Salminen S, Arvilommi H, Kero P, Koskinen P & Isolauri E (2001)Probiotics in primary prevention of atopic disease: A randomised placebo-controlled trial. Lancet 357, 1076-1079.
11. Camuesco D, Peran L, Comalada M, Nieto A, Di Stasi LC, Rodriguez-Cabezas ME, Concha A, Zarzuelo A & Galvez J (2005) Preventative effects of lactulose in the trinitrobenzene-sulphonic acid model of rat colitis. Inflamm Bowel Dis 11, 265-271.
12. Ritsema T & Smeekens S (2003) Fructans: Beneficial for plants and humans. Curr Opin Plant Biol 6, 223-230.
13. Ritsema T & Smeekens S (2003) Engineering fructan metabolism in plants. J Plant Physiol 160, 811-820.
14. Weyens G, Ritsema T, Van Dun K, et al. (2004) Production of tailor-made fructans in sugar beet by expression of onion fructosyltransferase genes. Plant Biotechnol J 2, 321-327.
15. Bernet MF, Brassart D, Neeser JR & Servin AL (1994) Lactobacillus acidophilus LA 1 binds to cultured human intestinal cell lines and inhibits cell attachment and cell invasion by enterovirulent bacteria. Gut 35, 483-489.
16. Mack DR, Michail S, Wei S, McDougall L & Hollingsworth MA (1999) Probiotics inhibit enteropathogenic E. coli adherence in vitro by inducing intestinal mucin gene expression. Am J Physiol 276, G941-G950.
17. Tuomola EM, Ouwehand AC & Salminen SJ (1999) The effect of probiotic bacteria on the adhesion of pathogens to human intestinal mucus. FEMS Immunol Med Microbiol 26, 137-142.
18. Ouwehand AC, Salminen S & Isolauri E (2002) Probiotics: An overview of beneficial effects. Antonie Van Leeuwenhoek 82, 279-289.
19. Madsen K, Cornish A, Soper P, McKaigney C, Jijon H, Yachimec C, Doyle J, Jewell L & De Simone C (2001) Probiotic bacteria enhance murine and human intestinal epithelial barrier function. Gastroenterology 121, 580-591.
20. Shanahan F (2002) Probiotics and inflammatory bowel disease: From fads and fantasy to facts and future. Br J Nutr 88, Suppl. 1, S5-S9.
21. Pochard P, Gosset P, Grangette C, Andre C, Tonnel AB, Pestel J & Mercenier A (2002) Lactic acid bacteria inhibit TH2 cytokine production by mononuclear cells from allergic patients. J Allergy Clin Immunol 110, 617-623.
22. Tubelius P, Stan V & Zachrisson A (2005) Increasing work-place healthiness with the probiotic Lactobacillus reuteri: A randomised, double-blind placebo-controlled study. Environ Health 4, 25.
23. Peran L, Sierra S, Comalada M, et al. (2007) A comparative study of the preventative effects exerted by two probiotics, Lactobacillus reuteri and Lactobacillus fermentum, in the trinitrobenzenesulfonic acid model of rat colitis. Br J Nutr 97 96-103.
24. Lara-Villoslada F, de Haro O, Camuesco D, Comalada M, Velasco J, Zarzuelo A, Xaus J & Galvez J (2006) Short-chain fructooligosaccharides, in spite of being fermented in the upper part of the large intestine, have anti-inflammatory activity in the TNBS model of colitis. Eur J Nutr 45, 418-425.
25. 4+T cells via modulation of dendritic cell function. Am J Clin Nutr 80, 1618-1625.
26. Braat H, Rottiers P, Hommes DW, Huyghebaert N, Remaut E, Remon JP, van Deventer SJ, Neirynck S, Peppelenbosch MP & Steidler L (2006) A phase I trial with transgenic bacteria expressing interleukin-10 in Crohn's disease. Clin Gastroenterol Hepatol 4, 754-759.
27. Fukatsu K, Sakamoto S, Hara E, Ueno C, Maeshima Y, Matsumoto I, Mochizuki H & Hiraide H (2006) Gut ischemia-reperfusion affects gut mucosal immunity: A possible mechanism for infectious complications after severe surgical insults. Crit Care Med 34, 182-187.
28. Martin E, O'Sullivan B, Low P & Thomas R (2003) Antigenspecific suppression of a primed immune response by dendritic cells mediated by regulatory T cells secreting interleukin-10. Immunity 18, 155-167.
29. Boris S, Jimenez-Diaz R, Caso JL & Barbes C (2001) Partial characterization of a bacteriocin produced by Lactobacillus delbrueckii subsp. lactis UO004, an intestinal isolate with probiotic potential. J Appl Microbiol 91, 328-333.
30. Fernandez MF, Boris S & Barbes C (2003) Probiotic properties of human lactobacilli strains to be used in the gastrointestinal tract. J Appl Microbiol 94, 449-455.
31. Rogelj I, Bogovic Matijasic B, Canzek Majhenic A & Stojkovic S (2002) The survival and persistence of Lactobacillus acidophilus LF221 in different ecosystems. Int J Food Microbiol 76, 83-91.